SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-139043
Filing Date
2018-04-27
Accepted
2018-04-27 16:30:58
Documents
5
Period of Report
2018-06-07
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d437480ddef14a.htm DEF 14A 668028
2 GRAPHIC g437480g02x27.jpg GRAPHIC 76818
3 GRAPHIC g437480g03h91.jpg GRAPHIC 58082
4 GRAPHIC g437480g17v71.jpg GRAPHIC 18671
5 GRAPHIC g437480g29h98.jpg GRAPHIC 22894
  Complete submission text file 0001193125-18-139043.txt   912765
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35347 | Film No.: 18784431
SIC: 2834 Pharmaceutical Preparations